Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy

Modified Deep Lateral Wall Decompression and/or Deep Medial Wall Decompression for Moderate-to-severe Grave's Ophthalmopathy: a Prospective Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.

Who May Be Eligible (Plain English)

Who May Qualify: 1. EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy; 2. CAS≤3 score; 3. stable thyroid function for at least 6 months; 4. able and willing to participate in clinical trials and ensure regular follow-up; Who Should NOT Join This Trial: 1. any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors); 2. B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.); 3. uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases 4. those who were considered by the researchers to be excluded Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy; 2. CAS≤3 score; 3. stable thyroid function for at least 6 months; 4. able and willing to participate in clinical trials and ensure regular follow-up; Exclusion Criteria: 1. any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors); 2. B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.); 3. uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases 4. those who were considered by the researchers to be excluded

Treatments Being Tested

PROCEDURE

modified deep lateral and/or medial wall decompression

Modified deep lateral orbital wall decompression is based on traditional outer wall decompression with combined abrasion of the deep outer orbital wall (including the greater pterygoid wing) to achieve adequate enlargement of the orbital cavity.

Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China